← Evidence map

ReviewBiomedicines2022

Site-Specific Considerations on Engineered T Cells for Malignant Gliomas.

Nirmeen Elmadany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35885047